Long-term monotherapy with ticagrelor after coronary stenting: the GLOBAL LEADERS study

Dual antiplatelet treatment is currently the mainstay of pharmacologic treatment for patients after coronary percutaneous interventions for stable or acute coronary syndrome. The treatment decreases the incidence of thrombotic complications, but is responsible for an increased risk of bleeding. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Antonio, Capodanno, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270912/
https://www.ncbi.nlm.nih.gov/pubmed/32523438
http://dx.doi.org/10.1093/eurheartj/suaa058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270912/
https://www.ncbi.nlm.nih.gov/pubmed/32523438
http://dx.doi.org/10.1093/eurheartj/suaa058

Ejemplares similares